Healthcare and life sciences industry leaders optimistic despite historic upheavals and great uncertainty


The recently released 2023 Healthcare and Life Sciences Investment Outlook from KPMG finds turbulence, and opportunity, in this post-pandemic marketplace.

The extensive global research and annual survey of corporate and private equity deal makers analyzes how eight industry subsectors fared during a year characterized by macroeconomic and geopolitical upheaval, and how deal activity and market drivers could shape the 2023 investment landscape.

After years propelled by rapid innovation and strong…

Previous Florida businesses, consumers could see tax breaks
Next Sweet deal: Krispy Kreme sells Winston-Salem property to Goodwill, will lease it back